Abivax treated first patient in phase 2b/3 ABX464 Covid-19 clinical trial
On Jul. 2, 2020, French biotech company Abivax announced it had has treated the first patient in a…
-
-
Regeneron and Sanofi announced Kevzara (sarilumab) phase 3 US trial in COVID-19 patients did not meet endpoints
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
-
AgReliant Genetics was founded
Jul. 1, 2020, was the twentieth anniversary of AgReliant Genetics’ founding by global seed companies KWS of Einbeck,…
-
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage…
-
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS received CE marking
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
-
ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…
-
Abivax received ANSM and ethics committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized phase 2b/3 clinical trial
On May 14, 2020 Abivax announced it had received clearance from France’s National Agency for the Safety of…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launch
On May 6, 2020, bioMerieux announced performance validation and the upcoming launch of VIDAS® anti-SARS-CoV-2 serology tests to detect…
-
BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
-
Valneva and Pfizer announced a collaboration to co-develop and commercialize Lyme disease vaccine
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
-
Regeneron and Sanofi updated phase 2/3 adaptive-designed trial of Kevzara (sarilumab) in hospitalized COVID-19 patients
On Apr. 27, 2020, Regeneron and Sanofi announced preliminary results from the Phase 2 portion of an ongoing…
-
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
-
Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
On Apr. 22, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…
-
Sartorius Stedim Biotech delivered indispensable biopharma supplies
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
-
First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMerieux
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
-
World War I Killer Took Almost as Many US Troops’ Lives as Combat
On Aug. 29, 2018, one hundred years ago, there were two major killers in the world: World War…
-
Biotechnology | CDC | Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
CDC published ACIP’s recommendations for use of MenACWY-CRM vaccine in children age 2-23 months at increased risk for meningococcal disease
On Jun. 20, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
-
FDA approved Fluzone as the third quadrivalent influenza vaccine licensed for US use
On Jun. 10, 2013, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
-
Sanofi Pasteur opened a $101 million vaccine research and development facility at Connaught Campus in Toronto
On Jun. 22, 2011, Sanofi Pasteur opened a $101 million dollar vaccine research and development facility at Sanofi…
-
Biotechnology | FDA | Polio | Vaccine
FDA licensed Sanofi Pasteur’s new pediatric combination vaccine, Pentacel
On Jun. 23, 2008, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had licensed Pentacel, Diphtheria…
-
HHS awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities
On Jun. 14, 2007, the U.S. Department of Health and Human Services (HHS) awarded $132.5 million to Sanofi…
-
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) announced it had expanded the approved age…
-
First cloned horse was born in North America
On Mar. 13, 2005, Paris Texas, the first cloned horse in North America was born at the College…
-
The Nobel Prize in Chemistry was awarded to Marie Curie
On Nov. 7, 1911, Marie Curie’s birthday (born 1867), she was awarded the Nobel Prize in Chemistry “in…
-
pierre and marie Curie, vanity fair
Caricature of Pierre and Marie Curie. Caption read “Radium.” Published in Vanity Fair, December 22, 1904. In 1903,…
-
Marie and Pierre Curie isolated a new element that came to be called ‘radium’
In 1903, the Nobel Prize in Physics was divided, one half awarded to Antoine Henri Becquerel “in recognition…
-
Radium was found effective in the treatment of tumors
In 1903, radium was found effective in the treatment of tumors which Marie and Pierre Curie had isolated,…
-
Marie Curie Sklodowska, won a share of the Nobel Prize in Physics “in recognition of the extraordinary services on the radiation phenomena”
In 1903, Marie Curie Sklodowska, shared the Nobel Prize in Physics along with her husband Pierre Curie and…
-
Brain pathology and Parkinson’s disease was linked
On May 27, 1893, Paul Oscar Blocq and Georges Marinesco published ‘Tremblement Parkonsonien Hemiplegique‘ the first case that…
